Vialwirebiotech, curated
October 1, 2026, 5:31 PM
July 31, 2026
- 4:47 PM · Bloomberg — Technology4:47 PMIllumina CEO on Genomic Sequencing Opportunities and AI — Bloomberg — Technology
- 12:00 PM · BioWorld12:00 PMLow coffers, failed endometrial cancer trial: Karyopharm down 72% — BioWorld
- 12:00 PM · BioWorld12:00 PMWith sleep apnea drug under review, Apnimed prices $192M IPO — BioWorld
- 12:00 PM · BioWorld12:00 PMMimedx to buy Sanara for $350M to move beyond wound care — BioWorld
- 11:45 AM · BioPharma Dive11:45 AMResilience and Lilly invest $750M to boost Cincinnati drug production — BioPharma Dive
- 10:42 AM · Drug Discovery World10:42 AMTreatment underway for nonobstructive hypertrophic cardiomyopathy — Drug Discovery World
- 9:19 AM · Drug Discovery World9:19 AMGSK teams up with Relation to improve disease biology knowledge — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMTSC Alliance and Apertura Gene Therapy collaboration progresses — BioWorld
- 9:00 AM · BioWorld9:00 AMOlix’s OLX-501A reduces visceral fat in obese NHPs — BioWorld
- 9:00 AM · BioWorld9:00 AMLiver-targeted ASO tackles early MASLD — BioWorld
- 9:00 AM · BioWorld9:00 AMApex Bioscience discovers new PDE4 and PDE5 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMTuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMTahrget Therapeutics discloses new viral DNA polymerase inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMTaisho licenses Japanese rights to Kaigene’s KG-006 — BioWorld
- 9:00 AM · BioWorld9:00 AMSitala Bio identifies new complement factor B inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMUMF-814A sheds light on spliceosome-mutant myeloid disorders — BioWorld
- 9:00 AM · BioWorld9:00 AMMira advances MIRA-55 and SKNY-1 — BioWorld
- 9:00 AM · BioWorld9:00 AMCreate Medicines’ CRT-402 cleared to enter clinic in Australia — BioWorld
- 9:00 AM · BioWorld9:00 AMSunrock Biopharma reports new CCR9-targeting ADCs — BioWorld
- 8:32 AM · STAT News
- 6:57 AM · Pharmaceutical Technology6:57 AMSublingual semaglutide offered to UK practices despite Novo Nordisk concerns — Pharmaceutical Technology
- 5:58 AM · Pharmaceutical Technology5:58 AMmiRecule and Rio Biofarma to develop RNA therapeutic delivery technologies — Pharmaceutical Technology
- 4:47 AM · Drug Discovery World4:47 AMVerdiva Bio initiates Phase I study of obesity drug — Drug Discovery World
- 4:00 AM · Labiotech (EU)4:00 AMGain Therapeutics: a first-in-class, disease-modifying therapy for Parkinson’s — Labiotech (EU)
July 30, 2026
- 4:12 PM · BioPharma Dive4:12 PMAlnylam plunges as earnings deliver ‘one-two punch’ — BioPharma Dive
- 1:10 PM · MIT Technology Review1:10 PMMontana’s plan to become an experimental medical hub just pushed forward — MIT Technology Review
- 11:52 AM · BioPharma Dive11:52 AMJ&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B — BioPharma Dive
- 11:33 AM · Pharmaceutical Technology11:33 AMPfizer seeks label expansion for Litfulo after double Phase III NSV win — Pharmaceutical Technology
- 10:07 AM · Pharmaceutical Technology10:07 AMAustralia approves first-in-class Niktimvo for later-line cGVHD — Pharmaceutical Technology
- 9:12 AM · PharmaVoice9:12 AMHow Telix landed a $2.1 billion radiopharma deal with Regeneron — PharmaVoice
- 9:00 AM · BioWorld9:00 AMAbcellera and Vertex partner on TCEs for autoimmune diseases — BioWorld
- 9:00 AM · BioWorld9:00 AMSeed funding at Adjuvia to treat mitochondrial dysfunction — BioWorld
- 9:00 AM · BioWorld9:00 AMQnovia licenses antimicrobial peptide from University of Virginia — BioWorld
- 9:00 AM · BioWorld9:00 AMElix and University of Vienna collaborate on AI drug discovery — BioWorld
- 9:00 AM · BioWorld9:00 AMIksuda’s IKS-04 gains IND clearance for gastrointestinal cancers — BioWorld
- 8:00 AM · Pharmaceutical Executive8:00 AM<![CDATA[DSCSA Compliance Guide: What to do now that enforcement as begun]]> — Pharmaceutical Executive
- 7:00 AM · Drug Discovery World7:00 AMQureight closes $20 million Series B financing — Drug Discovery World
- 5:41 AM · Pharmaceutical Technology5:41 AMAmgen’s Repatha receives positive CHMP opinion for broader cardiovascular use — Pharmaceutical Technology
- 5:00 AM · Pharmaceutical Technology5:00 AMSynlogic and Caldera sign merger agreement — Pharmaceutical Technology
- 4:57 AM · Drug Discovery World4:57 AMPerspective receives European orphan medicinal product designation — Drug Discovery World
- 3:20 AM · Bloomberg — Technology3:20 AMEuropean Stocks Advance on Busy Earnings Day; Sanofi Slumps — Bloomberg — Technology